Major clinical problem with prostate cancer is the cell's ability to survive and proliferate upon androgen withdrawal. Indeed, deregulated cell differentiation and proliferation together with the suppression of apoptosis provides the condition for abnormal tissue growth. Here we examine the differential role of TRP channels in the control of Ca 2+ homeostasis and growth of prostate cancer cells.
Introduction
Prostate cancer (PC) is one of the leading threats to men's health. Its early stage depends on androgens for growth and survival, and androgen ablation therapy may at this time be effective in causing tumor to regress, however, in the late androgen-independent stage there is currently no successful therapy. It is, therefore, vital to understand what drives the progression to androgen independence. This latter is associated with the appearance of new cell phenotypes, characterized by apoptosis inhibition and the aberrant cell proliferation.
Deregulated cell differentiation and proliferation together with the suppression of apoptosis provide the condition for abnormal tissue growth, which ultimately can turn into uncontrolled expansion and invasion characteristic of cancer.
The role of calcium (Ca 2+ ) in the overall of cancer-related cell signalling pathways is uncontested. Alterations in Ca 2+ homeostasis have been described to increase proliferation [1, 2] , to induce differentiation [3] or apoptosis [4] [5] [6] . According to a growing number of studies, cationic channels in the TRP (Transient Receptor Potential) family would be key players of -2 -calcium homeostasis and cell physiopathology. During the last years it has emerged that several members of the TRP family could play an important role in prostate carcinogenesis and even more, some of them have been suggested as a prognostic markers for PCa especially useful in the differential diagnosis [6] .
Here we examine the differential role of TRP channels in Ca 2+ homeostasis of PC epithelial cells and their respective role in prostate carcinogenesis. Recent progress achieved in our understanding of molecular mechanisms of TRP channels signalling involved in the control of PC progression ensures that sooner or later fundamental breakthroughs will make their way to practical implications. non-specific cationic channels leading to ACE [7] .
Agonist
Interestingly, we have also shown that in contrast to the stimulatory role of α1-ARs on prostate cancer cell growth, metabotropic purinergic receptors (P2Y-R) are involved in the growth arrest of human prostate cancer cells [8] . Such divergent effects of two receptors on cell proliferation are surprising, since both α1-AR and P2Y-R are known to be coupled to the common phospholipase C catalyzed inositol phospholipids breakdown signalling pathway, via -dependent activation of the NFAT transcription factor) could potentially represent a suitable target for therapeutic intervention.
TRPM8 localization and function in prostate depends on the differentiation status: role in carcinogenesis
TRPM8 is a so-called "cold" receptor belonging to melastatin (TRPM) subfamily of TRP channels and is activated by cooling temperatures and menthol. Aside from sensory neurons, in which the role of TRPM8 in mediating cold-evoked excitation is fairly well established [9, 10] , this channel is most abundantly expressed in the prostate. In fact, TRPM8 was first cloned from the human prostate as prostate-specific gene [11] , even before its role in the cold sensation was established. Moreover, whilst remaining at moderate levels in normal prostate, TRPM8 expression strongly increases in prostate cancer. Despite the growing numbers of studies, the role of TRPM8 in prostate remains unclear, and it has been suggested to be involved in secretion function of the prostate and in the regulation of proliferation and/or apoptosis [12, 13] .
It has been also shown that anti-androgen therapy greatly reduced the expression of TRPM8, suggesting that TRPM8 is regulated by androgens [14] . We have demonstrated that in prostate cancer cell lines, and in primary cultures of normal, hyperplasic and cancerous prostate epithelial cells, TRPM8 is a target gene of the androgen receptor [12] . TRPM8
expression silencing experiments using siRNA suggest that the Ca 2+ inflow through TRPM8
plays an essential role in cellular Ca 2+ homeostasis in prostate epithelial cells and is involved in cell survival [13] .
Our results [15] and those of Barrit's group [13] indicate that TRPM8 may be expressed not just in the plasma membrane, but also in the endoplasmic reticulum (ER) membrane. Dual localization and channel-like function of TRPM8 in the two membranes significantly broaden the spectrum of physiological and pathological processes it may be involved in. However, the mechanisms which determine the preferred localization of TRPM8 Schematic diagram showing in simplified form differential TRPM8 localization and function depending on AR activity of human prostate epithelial cells and on their differentiation status.
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